BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38412651)

  • 21. Design and screening of a novel neuropilin-1 targeted penetrating peptide for anti-angiogenic therapy in glioma.
    Zhao L; Chen H; Lu L; Zhao C; Malichewe CV; Wang L; Guo X; Zhang X
    Life Sci; 2021 Apr; 270():119113. PubMed ID: 33508290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclic hexapeptide-conjugated nanoparticles enhance curcumin delivery to glioma tumor cells and tissue.
    Zhang X; Li X; Hua H; Wang A; Liu W; Li Y; Fu F; Shi Y; Sun K
    Int J Nanomedicine; 2017; 12():5717-5732. PubMed ID: 28848349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ligand-Modified Cell Membrane Enables the Targeted Delivery of Drug Nanocrystals to Glioma.
    Chai Z; Ran D; Lu L; Zhan C; Ruan H; Hu X; Xie C; Jiang K; Li J; Zhou J; Wang J; Zhang Y; Fang RH; Zhang L; Lu W
    ACS Nano; 2019 May; 13(5):5591-5601. PubMed ID: 31070352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A7RC peptide modified paclitaxel liposomes dually target breast cancer.
    Cao J; Wang R; Gao N; Li M; Tian X; Yang W; Ruan Y; Zhou C; Wang G; Liu X; Tang S; Yu Y; Liu Y; Sun G; Peng H; Wang Q
    Biomater Sci; 2015 Dec; 3(12):1545-54. PubMed ID: 26291480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DA7R: A 7-Letter Zip Code to Target PDAC.
    Parrasia S; Rossa A; Roncaglia N; Mattarei A; Honisch C; Szabò I; Ruzza P; Biasutto L
    Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor homing cell penetrating peptide decorated nanoparticles used for enhancing tumor targeting delivery and therapy.
    Gao H; Zhang Q; Yang Y; Jiang X; He Q
    Int J Pharm; 2015 Jan; 478(1):240-250. PubMed ID: 25448586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands.
    Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W
    J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved breast cancer cell-specific intracellular drug delivery and therapeutic efficacy by coupling decoration with cell penetrating peptide and SP90 peptide.
    Fan LQ; Du GX; Li PF; Li MW; Sun Y; Zhao LM
    Biomed Pharmacother; 2016 Dec; 84():1783-1791. PubMed ID: 27899251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Membrane permeation of arginine-rich cell-penetrating peptides independent of transmembrane potential as a function of lipid composition and membrane fluidity.
    Wallbrecher R; Ackels T; Olea RA; Klein MJ; Caillon L; Schiller J; Bovée-Geurts PH; van Kuppevelt TH; Ulrich AS; Spehr M; Adjobo-Hermans MJW; Brock R
    J Control Release; 2017 Jun; 256():68-78. PubMed ID: 28411183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and Development of Polysaccharide-Doxorubicin-Peptide Bioconjugates for Dual Synergistic Effects of Integrin-Targeted and Cell-Penetrating Peptides for Cancer Chemotherapy.
    Mansur AAP; Carvalho SM; Lobato ZIP; Leite MF; Cunha ADS; Mansur HS
    Bioconjug Chem; 2018 Jun; 29(6):1973-2000. PubMed ID: 29790738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted Modification of the Cationic Anticancer Peptide HPRP-A1 with iRGD To Improve Specificity, Penetration, and Tumor-Tissue Accumulation.
    Hu C; Huang Y; Chen Y
    Mol Pharm; 2019 Feb; 16(2):561-572. PubMed ID: 30592418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcytosable Peptide-Paclitaxel Prodrug Nanoparticle for Targeted Treatment of Triple-Negative Breast Cancer.
    Wang L; Zhao C; Lu L; Jiang H; Wang F; Zhang X
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glioma Dual-Targeting Nanohybrid Protein Toxin Constructed by Intein-Mediated Site-Specific Ligation for Multistage Booster Delivery.
    Chen Y; Zhang M; Jin H; Li D; Xu F; Wu A; Wang J; Huang Y
    Theranostics; 2017; 7(14):3489-3503. PubMed ID: 28912890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Novel Blood-Brain Barrier-Penetrating and Vascular-Targeting Chimeric Peptide Inhibits Glioma Angiogenesis.
    Lu L; Wang L; Zhao L; Liao J; Zhao C; Xu X; Wang F; Zhang X
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and Synthesis of a Peptide-Based Glioma-Targeted Drug Delivery Vector gHope2.
    Kurrikoff K; Oskolkov N; Eriste E; Langel Ü
    Methods Mol Biol; 2021; 2355():117-129. PubMed ID: 34386955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acid-Induced Activated Cell-Penetrating Peptide-Modified Cholesterol-Conjugated Polyoxyethylene Sorbitol Oleate Mixed Micelles for pH-Triggered Drug Release and Efficient Brain Tumor Targeting Based on a Charge Reversal Mechanism.
    Tian Y; Mi G; Chen Q; Chaurasiya B; Li Y; Shi D; Zhang Y; Webster TJ; Sun C; Shen Y
    ACS Appl Mater Interfaces; 2018 Dec; 10(50):43411-43428. PubMed ID: 30508486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glioma targeting peptide modified apoferritin nanocage.
    Zhai M; Wang Y; Zhang L; Liang M; Fu S; Cui L; Yang M; Gong W; Li Z; Yu L; Xie X; Yang C; Yang Y; Gao C
    Drug Deliv; 2018 Nov; 25(1):1013-1024. PubMed ID: 29726297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides.
    Gao W; Xiang B; Meng TT; Liu F; Qi XR
    Biomaterials; 2013 May; 34(16):4137-4149. PubMed ID: 23453200
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.